Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
Is a |
Product containing neomycin (medicinal product) |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
Is a |
dexamethasonnatriumphosphat |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
Is a |
kombinationspræparater med neomycin |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin (substance) |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dexamethasone ophthalmic preparation |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Dexamethasone sodium phosphate (substance) |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
Is a |
dexamethasonnatriumphosphat +neomycinsulfat |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Neomycin sulfate |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Antiinfektiøst middel til huden |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Corticosterone |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
binyrehormonmiddel |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Baktericid |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
glucocorticoidhormon |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Local anti-infective |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
Has manufactured dose form |
Ocular dose form (dose form) |
false |
Inferred relationship |
Some |
|
|
dexamethasonnatriumphosphat 1 mg +neomycinsulfat 3,5 mg opløsning |
Has manufactured dose form |
lægemiddelopløsning |
false |
Inferred relationship |
Some |
|
|